tetano
Editor, Senior Moderator
Endosc Ultrasound
. 2020 Jul 30.
doi: 10.4103/eus.eus_45_20. Online ahead of print.
Expert panel consensus statement on the applications and precaution strategies of bronchoscopy in patients with COVID-19
Huizhen Yang[SUP] 1 [/SUP], Huidong Chen[SUP] 2 [/SUP], Baoan Gao[SUP] 3 [/SUP], Weining Xiong[SUP] 4 [/SUP], Xiaoju Zhang[SUP] 5 [/SUP], D Kyle Hogarth[SUP] 6 [/SUP], Jiayuan Sun[SUP] 7 [/SUP], Mingyao Ke[SUP] 8 [/SUP], Felix J F Herth[SUP] 9 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with higher transmissibility compared with SARS coronavirus (SARS-CoV) and Middle East respiratory distress syndrome coronavirus. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an unprecedented global crisis that has not been experienced, which is still disrupting health systems, economies, and societies around the world by the rapid spread. Bronchoscopy plays an important role in diagnosis and therapy of pulmonary diseases, especially in patients with severe pulmonary infection, however, application of bronchoscopy in patients suspected or confirmed SARS-CoV-2 infection is extremely limited for the potential airborne transmission from aerosol generated during the procedure. This consensus statement was completed by expert panel of Interventional & Minimally Invasive Respiratory Committee of China Medical Education Association, and the issues were summarized as seven key topics to define the indications of bronchoscopy and matters needing attentions on the bronchoscopy procedures in patients with COVID-19, as well as the protective precaution strategies to avoid nosocomial SARS-CoV-2 infection.
Keywords: bronchoscopy; consensus; coronavirus disease 2019.
. 2020 Jul 30.
doi: 10.4103/eus.eus_45_20. Online ahead of print.
Expert panel consensus statement on the applications and precaution strategies of bronchoscopy in patients with COVID-19
Huizhen Yang[SUP] 1 [/SUP], Huidong Chen[SUP] 2 [/SUP], Baoan Gao[SUP] 3 [/SUP], Weining Xiong[SUP] 4 [/SUP], Xiaoju Zhang[SUP] 5 [/SUP], D Kyle Hogarth[SUP] 6 [/SUP], Jiayuan Sun[SUP] 7 [/SUP], Mingyao Ke[SUP] 8 [/SUP], Felix J F Herth[SUP] 9 [/SUP]
Affiliations
- PMID: 32769235
- DOI: 10.4103/eus.eus_45_20
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with higher transmissibility compared with SARS coronavirus (SARS-CoV) and Middle East respiratory distress syndrome coronavirus. Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an unprecedented global crisis that has not been experienced, which is still disrupting health systems, economies, and societies around the world by the rapid spread. Bronchoscopy plays an important role in diagnosis and therapy of pulmonary diseases, especially in patients with severe pulmonary infection, however, application of bronchoscopy in patients suspected or confirmed SARS-CoV-2 infection is extremely limited for the potential airborne transmission from aerosol generated during the procedure. This consensus statement was completed by expert panel of Interventional & Minimally Invasive Respiratory Committee of China Medical Education Association, and the issues were summarized as seven key topics to define the indications of bronchoscopy and matters needing attentions on the bronchoscopy procedures in patients with COVID-19, as well as the protective precaution strategies to avoid nosocomial SARS-CoV-2 infection.
Keywords: bronchoscopy; consensus; coronavirus disease 2019.